Abstract

Fifty years ago, people with sickle cell disease (SCD) were discouraged from becoming pregnant, but now, most should be supported if they choose to pursue a pregnancy. They and their providers, however, should be aware of the physiological changes of pregnancy that aggravate SCD and pregnancy’s unique maternal and fetal challenges. Maternal problems can arise from chronic underlying organ dysfunction such as renal disease or pulmonary hypertension; from acute complications of SCD such as acute anemia, vaso-occlusive crises, and acute chest syndrome; and/or from pregnancy-related complications such as preeclampsia, sepsis, severe anemia, thromboembolism, and the need for cesarean delivery. Fetal problems include alloimmunization, opioid exposure, fetal growth restriction, preterm delivery, and stillbirth. Before and during pregnancy, in addition to the assessment and care that every pregnant patient should receive, patients with SCD should be evaluated and treated by a multidisciplinary team with respect to their unique maternal and fetal issues.

1.
Telfer
P
,
Coen
P
,
Chakravorty
S
, et al
.
Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London
.
Haematologica
.
2007
;
92
(
7
):
905
-
912
.
2.
Quinn
CT
,
Rogers
ZR
,
McCavit
TL
,
Buchanan
GR
.
Improved survival of children and adolescents with sickle cell disease
.
Blood
.
2010
;
115
(
17
):
3447
-
3452
.
3.
Platt
OS
,
Brambilla
DJ
,
Rosse
WF
, et al
.
Mortality in sickle cell disease. Life expectancy and risk factors for early death
.
N Engl J Med
.
1994
;
330
(
23
):
1639
-
1644
.
4.
Brosens
I
,
Puttemans
P
,
Benagiano
G
.
Placental bed research: I. The placental bed: from spiral arteries remodeling to the great obstetrical syndromes
.
Am J Obstet Gynecol
.
2019
;
221
(
5
):
437
-
456
.
5.
Villers
MS
,
Jamison
MG
,
De Castro
LM
,
James
AH
.
Morbidity associated with sickle cell disease in pregnancy
.
Am J Obstet Gynecol
.
2008
;
199
(
2
):
125.e1
-
125.e5
.
6.
Barfield
WD
,
Barradas
DT
,
Manning
SE
,
Kotelchuck
M
,
Shapiro-Mendoza
CK
.
Sickle cell disease and pregnancy outcomes: women of African descent
.
Am J Prev Med
.
2010
;
38
(
4 suppl
):
S542
-
S549
.
7.
Alayed
N
,
Kezouh
A
,
Oddy
L
,
Abenhaim
HA
.
Sickle cell disease and pregnancy outcomes: population-based study on 8.8 million births
.
J Perinat Med
.
2014
;
42
(
4
):
487
-
492
.
8.
Boulet
SL
,
Okoroh
EM
,
Azonobi
I
,
Grant
A
,
Craig Hooper
W
.
Sickle cell disease in pregnancy: maternal complications in a Medicaid-enrolled population
.
Matern Child Health J
.
2013
;
17
(
2
):
200
-
207
.
9.
Roberts
JM
,
Taylor
RN
,
Musci
TJ
,
Rodgers
GM
,
Hubel
CA
,
McLaughlin
MK
.
Preeclampsia: an endothelial cell disorder
.
Am J Obstet Gynecol
.
1989
;
161
(
5
):
1200
-
1204
.
10.
Oteng-Ntim
E
,
Meeks
D
,
Seed
PT
, et al
.
Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis
.
Blood
.
2015
;
125
(
21
):
3316
-
3325
.
11.
Kourtis
AP
,
Read
JS
,
Jamieson
DJ
.
Pregnancy and infection
.
N Engl J Med
.
2014
;
370
(
23
):
2211
-
2218
.
12.
Robinson
DP
,
Klein
SL
.
Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis
.
Horm Behav
.
2012
;
62
(
3
):
263
-
271
.
13.
Jamieson
DJ
,
Rasmussen
SA
.
An update on COVID-19 and pregnancy
.
Am J Obstet Gynecol
.
2022
;
226
(
2
):
177
-
186
.
14.
Booth
C
,
Inusa
B
,
Obaro
SK
.
Infection in sickle cell disease: a review
.
Int J Infect Dis
.
2010
;
14
(
1
):
e2
-
e12
.
15.
Early
ML
,
Eke
AC
,
Gemmill
A
,
Lanzkron
S
,
Pecker
LH
.
Severe maternal morbidity and mortality in sickle cell disease in the National Inpatient Sample, 2012-2018
.
JAMA Netw Open
.
2023
;
6
(
2
):
e2254552
.
16.
Richani
K
,
Soto
E
,
Romero
R
, et al
.
Normal pregnancy is characterized by systemic activation of the complement system
.
J Matern Fetal Neonatal Med
.
2005
;
17
(
4
):
239
-
245
.
17.
Efrati
P
,
Presentey
B
,
Margalith
M
,
Rozenszajn
L
.
Leukocytes of normal pregnant women
.
Obstet Gynecol
.
1964
;
23
:
429
-
432
.
18.
Osunkwo
I
,
Manwani
D
,
Kanter
J
.
Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease
.
Ther Adv Hematol
.
2020
;
11
:
2040620720955000
.
19.
Gavriilaki
E
,
Mainou
M
,
Christodoulou
I
, et al
.
In vitro evidence of complement activation in patients with sickle cell disease
.
Haematologica
.
2017
;
102
(
12
):
e481
-
e482
.
20.
Roumenina
LT
,
Chadebech
P
,
Bodivit
G
, et al
.
Complement activation in sickle cell disease: dependence on cell density, hemolysis and modulation by hydroxyurea therapy
.
Am J Hematol
.
2020
;
95
(
5
):
456
-
464
.
21.
Hytten
F
.
Blood volume changes in normal pregnancy
.
Clin Haematol
.
1985
;
14
(
3
):
601
-
612
.
22.
Yu
CK
,
Stasiowska
E
,
Stephens
A
,
Awogbade
M
,
Davies
A
.
Outcome of pregnancy in sickle cell disease patients attending a combined obstetric and haematology clinic
.
J Obstet Gynaecol
.
2009
;
29
(
6
):
512
-
516
.
23.
Al Jama
FE
,
Gasem
T
,
Burshaid
S
,
Rahman
J
,
Al Suleiman
SA
,
Rahman
MS
.
Pregnancy outcome in patients with homozygous sickle cell disease in a university hospital, Eastern Saudi Arabia
.
Arch Gynecol Obstet
.
2009
;
280
(
5
):
793
-
797
.
24.
Sharif
J
,
Byrd
L
,
Stevenson
K
,
Raddats
J
,
Morsman
E
,
Ryan
K
.
Transfusion for sickle cell disease in pregnancy: a single-centre survey
.
Transfus Med
.
2018
;
28
(
3
):
231
-
235
.
25.
Sanghavi
M
,
Rutherford
JD
.
Cardiovascular physiology of pregnancy
.
Circulation
.
2014
;
130
(
12
):
1003
-
1008
.
26.
Gordeuk
VR
,
Castro
OL
,
Machado
RF
.
Pathophysiology and treatment of pulmonary hypertension in sickle cell disease
.
Blood
.
2016
;
127
(
7
):
820
-
828
.
27.
Klings
ES
,
Machado
RF
,
Barst
RJ
, et al
.
An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease
.
Am J Respir Crit Care Med
.
2014
;
189
(
6
):
727
-
740
.
28.
American College of Obstetricians and Gynecologists' Presidential Task Force on Pregnancy and Heart Disease and Committee on Practice Bulletins—Obstetrics
.
ACOG practice bulletin no. 212: pregnancy and heart disease
.
Obstet Gynecol
.
2019
;
133
(
5
):
e320
-
e356
.
29.
Hui
D
,
Hladunewich
MA
.
Chronic kidney disease and pregnancy
.
Obstet Gynecol
.
2019
;
133
(
6
):
1182
-
1194
.
30.
Lebensburger
JD
,
Derebail
VK
.
Sickle cell disease and the kidney: filters gone awry
.
Hematol Oncol Clin North Am
.
2022
;
36
(
6
):
1239
-
1254
.
31.
Bremme
KA
.
Haemostatic changes in pregnancy
.
Best Pract Res Clin Haematol
.
2003
;
16
(
2
):
153
-
168
.
32.
Hellgren
M
.
Hemostasis during normal pregnancy and puerperium
.
Semin Thromb Hemost
.
2003
;
29
(
2
):
125
-
130
.
33.
Heit
J
,
Kobbervig
C
,
James
A
,
Petterson
T
,
Bailey
K
,
Melton
LJ
.
Trends in the incidence of deep vein thrombosis and pulmonary embolism during pregnancy or the puerperium: a 30-year population-based study
.
Ann Intern Med
.
2005
;
143
(
10
):
697
.
34.
Tepper
NK
,
Boulet
SL
,
Whiteman
MK
, et al
.
Postpartum venous thromboembolism: incidence and risk factors
.
Obstet Gynecol
.
2014
;
123
(
5
):
987
-
996
.
35.
Brunson
A
,
Keegan
T
,
Mahajan
A
,
White
R
,
Wun
T
.
High incidence of venous thromboembolism recurrence in patients with sickle cell disease
.
Am J Hematol
.
2019
;
94
(
8
):
862
-
870
.
36.
Howard
RJ
,
Tuck
SM
,
Pearson
TC
.
Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome
.
Br J Obstet Gynaecol
.
1995
;
102
(
12
):
947
-
951
.
37.
Ngô
C
,
Kayem
G
,
Habibi
A
, et al
.
Pregnancy in sickle cell disease: maternal and fetal outcomes in a population receiving prophylactic partial exchange transfusions
.
Eur J Obstet Gynecol Reprod Biol
.
2010
;
152
(
2
):
138
-
142
.
38.
Costa
VM
,
Viana
MB
,
Aguiar
RA
.
Pregnancy in patients with sickle cell disease: maternal and perinatal outcomes
.
J Matern Fetal Neonatal Med
.
2014
;
28
(
6
):
685
-
689
.
39.
Agarwal
S
,
Stanek
JR
,
Vesely
SK
, et al
.
Pregnancy-related thromboembolism in women with sickle cell disease: an analysis of National Medicaid Data
.
Am J Hematol
.
2023
;
98
(
11
):
1677
-
1684
.
40.
James
AH
.
Iron deficiency anemia in pregnancy
.
Obstet Gynecol
.
2021
;
138
(
4
):
663
-
674
.
41.
Early
ML
,
Eke
AC
,
Gemmill
A
,
Lanzkron
S
,
Pecker
LH
.
Comparisons of severe maternal morbidity and other adverse pregnancy outcomes in pregnant people with sickle cell disease vs anemia
.
JAMA Netw Open
.
2023
;
6
(
2
):
e2254545
.
42.
Thame
M
,
Lewis
J
,
Trotman
H
,
Hambleton
I
,
Serjeant
G
.
The mechanisms of low birth weight in infants of mothers with homozygous sickle cell disease
.
Pediatrics
.
2007
;
120
(
3
):
e686
-
693
.
43.
Yazdanbakhsh
K
,
Ware
RE
,
Noizat-Pirenne
F
.
Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management
.
Blood
.
2012
;
120
(
3
):
528
-
537
.
44.
Fasano
RM
,
Meyer
EK
,
Branscomb
J
,
White
MS
,
Gibson
RW
,
Eckman
JR
.
Impact of red blood cell antigen matching on alloimmunization and transfusion complications in patients with sickle cell disease: a systematic review
.
Transfus Med Rev
.
2019
;
33
(
1
):
12
-
23
.
45.
Oakley
LL
,
Mitchell
S
,
von Rege
I
, et al
.
Perinatal outcomes in women with sickle cell disease: a matched cohort study from London, UK
.
Br J Haematol
.
2022
;
196
(
4
):
1069
-
1075
.
46.
Ha
TK
,
Boulet
SL
,
Cotsonis
G
,
Geary
F
,
Jamieson
DJ
,
Lindsay
M
.
Association of sickle cell disease with severe maternal morbidity
.
Obstet Gynecol
.
2023
;
141
(
1
):
163
-
169
.
47.
Boafor
TK
,
Olayemi
E
,
Galadanci
N
, et al
.
Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis
.
BJOG
.
2016
;
123
(
5
):
691
-
698
.
48.
Brown
AK
,
Sleeper
LA
,
Pegelow
CH
,
Miller
ST
,
Gill
FM
,
Waclawiw
MA
.
The influence of infant and maternal sickle cell disease on birth outcome and neonatal course
.
Arch Pediatr Adolesc Med
.
1994
;
148
(
11
):
1156
-
1162
.
49.
Thame
MM
,
Osmond
C
,
Serjeant
GR
.
Fetal growth in women with homozygous sickle cell disease: an observational study
.
Eur J Obstet Gynecol Reprod Biol
.
2013
;
170
(
1
):
62
-
66
.
50.
Serjeant
GR
,
Loy
LL
,
Crowther
M
,
Hambleton
IR
,
Thame
M
.
Outcome of pregnancy in homozygous sickle cell disease
.
Obstet Gynecol
.
2004
;
103
(
6
):
1278
-
1285
.
51.
Costa
S
,
Rocha
G
,
Leitão
A
,
Guimarães
H
.
Transient tachypnea of the newborn and congenital pneumonia: a comparative study
.
J Matern Fetal Neonatal Med
.
2011
;
25
(
7
):
992
-
994
.
52.
Fashakin
V
,
Weber
JM
,
Truong
T
,
Craig
A
,
Wheeler
SM
,
James
AH
.
Sickle cell disease and the incidence and etiology of preterm birth
.
Am J Obstet Gynecol MFM
.
2022
;
4
(
6
):
100723
.
53.
Muganyizi
PS
,
Kidanto
H
.
Sickle cell disease in pregnancy: trend and pregnancy outcomes at a tertiary hospital in Tanzania
.
PLoS One
.
2013
;
8
(
2
):
e56541
.
54.
Moise
KJ
,
Argoti
PS
.
Management and prevention of red cell alloimmunization in pregnancy: a systematic review
.
Obstet Gynecol
.
2012
;
120
(
5
):
1132
-
1139
.
55.
Brown
JA
,
Sinkey
RG
,
Steffensen
TS
,
Louis-Jacques
AF
,
Louis
JM
.
Neonatal Abstinence syndrome among infants born to mothers with sickle cell hemoglobinopathies
.
Am J Perinatol
.
2020
;
37
(
3
):
326
-
332
.
56.
Serjeant
GR
,
Hambleton
I
,
Thame
M
.
Fecundity and pregnancy outcome in a cohort with sickle cell-haemoglobin C disease followed from birth
.
BJOG
.
2005
;
112
(
9
):
1308
-
1314
.
57.
Wilson
NO
,
Ceesay
FK
,
Hibbert
JM
, et al
.
Pregnancy outcomes among patients with sickle cell disease at Korle-Bu Teaching Hospital, Accra, Ghana: retrospective cohort study
.
Am J Trop Med Hyg
.
2012
;
86
(
6
):
936
-
942
.
58.
Yawn
BP
,
Buchanan
GR
,
Afenyi-Annan
AN
, et al
.
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members
.
JAMA
.
2014
;
312
(
10
):
1033
-
1048
.
59.
Eke
AC
,
Gandhi
M
,
Kaimal
AJ
,
Moniz
M
,
Shields
A
. Hemoglobinopathies in Pregnancy Practice Advisory.
American College of Obstetricians and Gynecologists (ACOG)
;
2022
.
60.
Liem
RI
,
Lanzkron
S
,
D Coates
T
, et al
.
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease
.
Blood Adv
.
2019
;
3
(
23
):
3867
-
3897
.
61.
ACOG Committee on Obstetrics
.
ACOG practice bulletin no. 78: hemoglobinopathies in pregnancy
.
Obstet Gynecol
.
2007
;
109
(
1
):
229
-
237
.
62.
Brawley
OW
,
Cornelius
LJ
,
Edwards
LR
, et al
.
NIH Consensus development statement on hydroxyurea treatment for sickle cell disease
.
NIH Consens State Sci Statements
.
2008
;
25
(
1
):
1
-
30
.
63.
Stevenson
E
,
Tanabe
P
,
Knisely
M
, et al
.
Infertility and treatment-seeking practices among females and males with sickle cell disease in the Sickle Cell Disease Implementation Consortium registry
.
Pediatr Blood Cancer
.
2023
;
70
(
7
):
e30356
.
64.
Kroner
BL
,
Hankins
JS
,
Pugh
N
, et al
.
Pregnancy outcomes with hydroxyurea use in women with sickle cell disease
.
Am J Hematol
.
2022
;
97
(
5
):
603
-
612
.
65.
Kanter
J
,
Smith
WR
,
Desai
PC
, et al
.
Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects
.
Blood Adv
.
2020
;
4
(
16
):
3804
-
3813
.
66.
Gaston
MH
,
Verter
JI
,
Woods
G
, et al
.
Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial
.
N Engl J Med
.
1986
;
314
(
25
):
1593
-
1599
.
67.
Falletta
JM
,
Woods
GM
,
Verter
JI
, et al
.
Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II
.
J Pediatr
.
1995
;
127
(
5
):
685
-
690
.
68.
Oteng-Ntim
E
,
Pavord
S
,
Howard
R
, et al
.
Management of sickle cell disease in pregnancy. A British Society for Haematology Guideline
.
Br J Haematol
.
2021
;
194
(
6
):
980
-
995
.
69.
Duley
L
,
Henderson-Smart
DJ
,
Meher
S
,
King
JF
.
Antiplatelet agents for preventing pre-eclampsia and its complications
.
Cochrane Database Syst Rev
.
2007
(
2
):
CD004659
.
70.
Aghamolaei
T
,
Pormehr-Yabandeh
A
,
Hosseini
Z
,
Roozbeh
N
,
Arian
M
,
Ghanbarnezhad
A
.
Pregnancy in the sickle cell disease and fetomaternal outcomes in different sickle cell genotypes: a systematic review and meta-analysis
.
Ethiop J Health Sci
.
2022
;
32
(
4
):
849
-
864
.
71.
Koshy
M
,
Burd
L
,
Wallace
D
,
Moawad
A
,
Baron
J
.
Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study
.
N Engl J Med
.
1988
;
319
(
22
):
1447
-
1452
.
72.
Okusanya
BO
,
Oladapo
OT
.
Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy
.
Cochrane Database Syst Rev
.
2016
;
12
:
CD010378
.
73.
Malinowski
AK
,
Shehata
N
,
D'Souza
R
, et al
.
Prophylactic transfusion for pregnant women with sickle cell disease: a systematic review and meta-analysis
.
Blood
.
2015
;
126
(
21
):
2424
-
2435
. quiz 2437.
74.
Lari
NF
,
DeBaun
MR
,
Oppong
SA
.
The emerging challenge of optimal blood pressure management and hypertensive syndromes in pregnant women with sickle cell disease: a review
.
Expert Rev Hematol
.
2017
;
10
(
11
):
987
-
994
.
75.
Dumas
G
,
Habibi
A
,
Onimus
T
, et al
.
Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients
.
Blood
.
2016
;
127
(
8
):
1062
-
1064
.
76.
Cannas
G
,
Dubreuil
L
,
Fichez
A
,
Gerfaud-Valentin
M
,
Debard
AL
,
Hot
A
.
Delayed severe hemolytic transfusion reaction during pregnancy in a woman with beta-thalassemia intermediate: successful outcome after eculizumab administration
.
Am J Case Rep
.
2021
;
22
:
e931107
.
77.
Swartz
RH
,
Ladhani
NNN
,
Foley
N
, et al
.
Canadian stroke best practice consensus statement: secondary stroke prevention during pregnancy
.
Int J Stroke
.
2018
;
13
(
4
):
406
-
419
.
78.
Marti-Carvajal
AJ
,
Pena-Marti
GE
,
Comunian-Carrasco
G
,
Marti-Pena
AJ
.
Interventions for treating painful sickle cell crisis during pregnancy
.
Cochrane Database Syst Rev
.
2009
;
2009
(
1
):
CD006786
.
79.
Howard
J
,
Lee
SA
,
Inusa
B
, et al
.
Prevention of Morbidity in Sickle Cell Disease (POMS2a)-overnight auto-adjusting continuous positive airway pressure compared with nocturnal oxygen therapy: a randomised crossover pilot study examining patient preference and safety in adults and children
.
Trials
.
2019
;
20
(
1
):
442
.
You do not currently have access to this content.
Sign in via your Institution